Attovia Therapeutics, Inc. (ATTO) SEC Filings & Financial Intelligence
Attovia Therapeutics, Inc. (ATTO) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ATTO
CIK: 2058707
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMikayel Nazloyan
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4/A | 2026-10-08 | 2026-08-04 | 4/A Filing | 0001644888-26-000009 | View SEC Doc Filr Page |
| 4/A | 2026-10-08 | 2026-08-04 | 4/A Filing | 0001654907-26-000009 | View SEC Doc Filr Page |
| 3/A | 2026-10-08 | 2026-08-04 | 3/A Filing | 0001644888-26-000008 | View SEC Doc Filr Page |
| 3/A | 2026-10-08 | 2026-08-04 | 3/A Filing | 0001654907-26-000008 | View SEC Doc Filr Page |
| 10-Q | 2026-09-02 | 2026-06-30 | 10-Q | 0001193125-26-380228 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | 8-K | 0001193125-26-380215 | View SEC Doc Filr Page |
| 144 | 2026-08-28 | — | 144 Filing | 0000891836-26-000065 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-08-05 | FORM 4/A | 0001866174-26-000011 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-08-05 | FORM 4/A | 0000886982-26-000522 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-05 | FORM 4 | 0001866174-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-05 | FORM 4 | 0000886982-26-000495 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0001172661-26-003341 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-11 | — | SCHEDULE 13D Filing | 0001231919-26-000857 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-342487 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | FORM 4 | 0000905148-26-003548 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092867 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | 4 | 0001193125-26-340173 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-06 | 4 Filing | 0001231919-26-000838 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 | 0001193125-26-338446 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0001242882-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0002141590-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0002141655-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0002142262-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 | 0001193125-26-338430 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 | 0001193125-26-338420 | View SEC Doc Filr Page |